Chemotherapy for Oral and Maxillofacial Tumors: An Update

被引：12

作者：

Eid, Ahmed ^{[1
]}

Li, Shuang ^{[2
]}

Garza, Rodolfo ^{[2
]}

Wong, Mark E. ^{[2
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Gen Oncol, Houston, TX 77030 USA

[2] Univ Texas Hlth Sci Ctr Houston, Houston, TX 77030 USA

来源：

ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA | 2014年 / 26卷 / 02期

关键词：

Chemotherapy; Locally advanced; Maxillofacial tumors; Oral cavity tumors; Squamous cell carcinoma; SQUAMOUS-CELL CARCINOMA; LOCALLY ADVANCED HEAD; CISPLATIN PLUS FLUOROURACIL; COOPERATIVE-ONCOLOGY-GROUP; PHASE-III TRIAL; NECK-CANCER; POSTOPERATIVE IRRADIATION; INDUCTION CHEMOTHERAPY; CETUXIMAB; DOCETAXEL;

D O I：

10.1016/j.coms.2014.01.004

中图分类号：

R78 [口腔科学];

学科分类号：

1003 ;

摘要：

Surgery is the primary intervention in oral and maxillofacial tumors and under ideal circumstances is curative. There is no evidence to support the use of induction or adjuvant chemotherapy in initial therapy of early stage tumors. Locally advanced tumors, non-resectable tumors as well as recurrence in early stage disease, need a multi-modality therapeutic approach involving chemotherapy. Palliative chemotherapy plays an important role in the treatment patients with metastatic oral and maxillofacial tumors. Chemotherapy and targeted agents plays an important role in the treatment of patients with rare oral and maxillofacial tumors such as sarcomas, lymphomas, and giant cell tumors.

引用

页码：163 / +

页数：9

共 30 条

[1] Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck [J].

Argiris, A. ;

Kotsakis, A. P. ;

Hoang, T. ;

Worden, F. P. ;

Savvides, P. ;

Gibson, M. K. ;

Gyanchandani, R. ;

Blumenschein, G. R., Jr. ;

Chen, H. X. ;

Grandis, J. R. ;

Harari, P. M. ;

Kies, M. S. ;

Kim, S. .

ANNALS OF ONCOLOGY, 2013, 24 (01) :220-225

[2] Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer [J].

Bernier, J ;

Domenge, C ;

Ozsahin, M ;

Matuszewska, K ;

Lefèbvre, JL ;

Greiner, RH ;

Giralt, J ;

Maingon, P ;

Rolland, F ;

Bolla, M ;

Cognetti, F ;

Bourhis, J ;

Kirkpatrick, A ;

van Glabbeke, M .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (19) :1945-1952

[3] Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival [J].

Bonner, James A. ;

Harari, Paul M. ;

Giralt, Jordi ;

Cohen, Roger B. ;

Jones, Christopher U. ;

Sur, Ranjan K. ;

Raben, David ;

Baselga, Jose ;

Spencer, Sharon A. ;

Zhu, Junming ;

Youssoufian, Hagop ;

Rowinsky, Eric K. ;

Ang, K. Kian .

LANCET ONCOLOGY, 2010, 11 (01) :21-28

[4] Denosumab Induces Tumor Reduction and Bone Formation in Patients with Giant-Cell Tumor of Bone [J].

Branstetter, Daniel G. ;

Nelson, Scott D. ;

Manivel, J. Carlos ;

Blay, Jean-Yves ;

Chawla, Sant ;

Thomas, David M. ;

Jun, Susie ;

Jacobs, Ira .

CLINICAL CANCER RESEARCH, 2012, 18 (16) :4415-4424

[5]

Cohen EEW, 2012, J CLIN ONCOL, V30

[6] EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTOR AND SURVIVAL IN UPPER AERODIGESTIVE TRACT CANCER [J].

DASSONVILLE, O ;

FORMENTO, JL ;

FRANCOUAL, M ;

RAMAIOLI, A ;

SANTINI, J ;

SCHNEIDER, M ;

DEMARD, F ;

MILANO, G .

JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (10) :1873-1878

[7] Outcomes of Patients With Maxillofacial Osteosarcoma: A Review of 15 Cases [J].

DeAngelis, Adrian F. ;

Spinou, Catherine ;

Tsui, Alpha ;

Iseli, Tim ;

Desai, Jayesh ;

Wiesenfeld, David ;

Chandu, Arun .

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2012, 70 (03) :734-739

[8] Novel Oncologic, Surgical, and Prosthetic Treatment of High-Grade Surface Osteosarcoma, Osteoblastic Mandible Type [J].

Dhima, Matilda ;

Arce, Kevin ;

Moore, Eric J. ;

Rieck, Kevin L. ;

Salinas, Thomas J. .

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2013, 71 (05) :E224-E231

[9] RANDOMIZED COMPARISON OF CISPLATIN PLUS FLUOROURACIL AND CARBOPLATIN PLUS FLUOROURACIL VERSUS METHOTREXATE IN ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A SOUTHWEST-ONCOLOGY-GROUP STUDY [J].

FORASTIERE, AA ;

METCH, B ;

SCHULLER, DE ;

ENSLEY, JF ;

HUTCHINS, LF ;

TRIOZZI, P ;

KISH, JA ;

MCCLURE, S ;

VONFELDT, E ;

WILLIAMSON, SK ;

VONHOFF, DD .

JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (08) :1245-1251

[10] Randomized phase III evaluation of cisplatin plus fluorouracil versus cisplatin plus paclitaxel in advanced head and neck cancer (E1395): An intergroup trial of the eastern cooperative oncology group [J].

Gibson, MK ;

Li, Y ;

Murphy, B ;

Hussain, MHA ;

DeConti, RC ;

Ensley, J ;

Forastiere, AA .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) :3562-3567

← 1 2 3 →